In the BioHarmony Drug Report Database

"Preview" Icon

Edaravone

Radicava (edaravone) is a small molecule pharmaceutical. Edaravone was first approved as Radicava on 2017-05-05. It is used to treat amyotrophic lateral sclerosis in the USA.

 

Trade Name

 

Radicava
 

Common Name

 

edaravone
 

ChEMBL ID

 

CHEMBL290916
 

Indication

 

amyotrophic lateral sclerosis
 

Drug Class

 

Image (chem structure or protein)

Edaravone structure rendering